CUBIST PHARMACEUTICALS INC Contracts & Agreements

AGREEMENT AND PLAN OF MERGER among MERCK & CO., INC., MAVEC CORPORATION and CUBIST PHARMACEUTICALS, INC. Dated as of DECEMBER 8, 2014 (Filed With SEC on December 8, 2014)

CUBIST PHARMACEUTICALS, INC. 2014 SEVERANCE PLAN AND SUMMARY PLAN DESCRIPTION Effective December 8, 2014 (Filed With SEC on December 8, 2014)

CONFIDENTIAL TREATMENT AMENDMENT NO. 7 to the MANUFACTURING AND SUPPLY AGREEMENT entered into as of September 30, 2001 by and between ACS Dobfar, SpA and Cubist Pharmaceuticals,... (Filed With SEC on November 7, 2014)

CUBIST PHARMACEUTICALS, INC. 2014 OMNIBUS INCENTIVE PLAN STOCK OPTION AGREEMENT FOR DIRECTORS (Filed With SEC on August 11, 2014)

CUBIST PHARMACEUTICALS, INC. 2014 OMNIBUS INCENTIVE PLAN STOCK OPTION AGREEMENT FOR U.S. PARTICIPANTS (EMPLOYEES) (Filed With SEC on August 11, 2014)

CUBIST PHARMACEUTICALS, INC. 2014 OMNIBUS INCENTIVE PLAN STOCK OPTION AGREEMENT FOR NON-U.S. PARTICIPANTS (EMPLOYEES) (Filed With SEC on August 11, 2014)

CUBIST PHARMACEUTICALS, INC. 2014 OMNIBUS INCENTIVE PLAN RESTRICTED STOCK UNIT AGREEMENT FOR DIRECTORS (Filed With SEC on August 11, 2014)

CUBIST PHARMACEUTICALS, INC. 2014 OMNIBUS INCENTIVE PLAN RESTRICTED STOCK UNIT AGREEMENT FOR U.S. PARTICIPANTS (EMPLOYEES) (Filed With SEC on August 11, 2014)

CUBIST PHARMACEUTICALS, INC. 2014 OMNIBUS INCENTIVE PLAN RESTRICTED STOCK UNIT AGREEMENT FOR NON-U.S. PARTICIPANTS (EMPLOYEES) (Filed With SEC on August 11, 2014)

Short-Term Incentive Plan (STI Plan) Amended and Restated as of January 1, 2014 (Filed With SEC on February 25, 2014)

AMENDMENT # 3 to the LICENSE AGREEMENT (Filed With SEC on February 25, 2014)

AMENDMENT NO. 6 to the MANUFACTURING AND SUPPLY AGREEMENT entered into as of September 30, 2001 by and between ACS Dobfar, SpA and Cubist Pharmaceuticals, Inc. (Filed With SEC on November 12, 2013)

CONTINGENT VALUE RIGHTS AGREEMENT by and between Cubist Pharmaceuticals, Inc. and American Stock Transfer & Trust Company, LLC Dated as of October 24, 2013 (Filed With SEC on October 24, 2013)

CONTINGENT VALUE RIGHTS AGREEMENT (Filed With SEC on September 17, 2013)

CUBIST PHARMACEUTICALS, INC. 1.125% CONVERTIBLE SENIOR NOTES DUE 2018 INDENTURE DATED AS OF SEPTEMBER 10, 2013 THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., AS TRUSTEE (Filed With SEC on September 10, 2013)

CUBIST PHARMACEUTICALS, INC. 1.875% CONVERTIBLE SENIOR NOTES DUE 2020 INDENTURE DATED AS OF SEPTEMBER 10, 2013 THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., AS TRUSTEE (Filed With SEC on September 10, 2013)

Disclosure of Agency Relationship (Filed With SEC on September 10, 2013)

CUBIST PHARMACEUTICALS, INC. 1.125% CONVERTIBLE SENIOR NOTES DUE 2018 1.875% CONVERTIBLE SENIOR NOTES DUE 2020 PURCHASE AGREEMENT (Filed With SEC on September 5, 2013)

Disclosure of Agency Relationship (Filed With SEC on September 5, 2013)

AGREEMENT AND PLAN OF MERGER among: TRIUS THERAPEUTICS, INC., a Delaware corporation; CUBIST PHARMACEUTICALS, INC., a Delaware corporation; and BRGO CORPORATION, a Delaware... (Filed With SEC on August 1, 2013)

CONTINGENT VALUE RIGHTS AGREEMENT (Filed With SEC on August 1, 2013)

TENDER AND VOTING AGREEMENT (Filed With SEC on August 1, 2013)

Short-Term Incentive Plan (STI Plan) Amended and Restated as of January 1, 2013 (Filed With SEC on May 7, 2013)

Cubist Pharmaceuticals, Inc. Performance-Based Management Incentive Plan (Filed With SEC on May 7, 2013)

CONFIDENTIAL TREATMENT AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on May 7, 2013)

CUBIST PHARMACEUTICALS, INC. 2012 Equity Incentive Plan (Filed With SEC on February 27, 2013)

RESTRICTED STOCK UNIT AGREEMENT CUBIST PHARMACEUTICALS, INC. (Filed With SEC on February 27, 2013)

CUBIST PHARMACEUTICALS, INC. 2012 EQUITY INCENTIVE PLAN RESTRICTED STOCK UNIT AGREEMENT FOR NON-U.S. PARTICIPANTS (Filed With SEC on February 27, 2013)

PERFORMANCE UNIT AGREEMENT CUBIST PHARMACEUTICALS, INC. (Filed With SEC on February 27, 2013)

CUBIST PHARMACEUTICALS, INC. 2012 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT FOR NON-U.S. PARTICIPANTS (Filed With SEC on February 27, 2013)

STRICTLY CONFIDENTIAL (Filed With SEC on February 27, 2013)

CONFIDENTIAL TREATMENT Amendment #5 (Filed With SEC on February 27, 2013)

Short-Term Incentive Plan (STI Plan) Terms and Conditions (Filed With SEC on November 5, 2012)

Short-Term Incentive Plan (STI Plan) Terms and Conditions (Filed With SEC on May 1, 2012)

CUBIST PHARMACEUTICALS, INC. AMENDED AND RESTATED 2002 DIRECTORS EQUITY INCENTIVE PLAN (Filed With SEC on May 1, 2012)

Final Costs - Core and Shell (Filed With SEC on May 1, 2012)

OPTION AND LICENSE AGREEMENT (Filed With SEC on February 27, 2012)

Cubist Pharmaceuticals, Inc. Director Compensation, Benefits, Programs (Effective as of December 2, 2011) Director Compensation (Filed With SEC on February 27, 2012)

CUBIST PHARMACEUTICALS, INC. 2010 EQUITY INCENTIVE PLAN (Filed With SEC on November 2, 2011)

AGREEMENT AND PLAN OF MERGER AMONG CUBIST PHARMACEUTICALS, INC. FRD ACQUISITION CORPORATION AND ADOLOR CORPORATION Dated as of October 24, 2011 (Filed With SEC on October 24, 2011)

CONFIDENTIAL TREATMENT SETTLEMENT AND LICENSE AGREEMENT (Filed With SEC on July 29, 2011)

CONFIDENTIAL TREATMENT CO-PROMOTION AGREEMENT by and between CUBIST PHARMACEUTICALS, INC. and OPTIMER PHARMACEUTICALS, INC. Dated as of April 5, 2011 (Filed With SEC on July 29, 2011)

65 Hayden Avenue, Lexington, MA 02421 P ###-###-#### F ###-###-#### www.cubist.com (Filed With SEC on July 29, 2011)

AGREEMENT OF PURCHASE AND SALE BY AND BETWEEN THE REALTY ASSOCIATES FUND VI, L.P., AS SELLER, AND CUBIST PHARMACEUTICALS, INC. AS PURCHASER (Filed With SEC on July 29, 2011)

CONFIDENTIAL TREATMENT THIRD AMENDMENT TO DEVELOPMENT AND SUPPLY AGREEMENT (Filed With SEC on July 29, 2011)

Form of Non-statutory Stock Option Agreement for Employees in Italy (Filed With SEC on July 29, 2011)

CONFIDENTIAL TREATMENT Amendment # 4 (Filed With SEC on April 29, 2011)

FACE OF SECURITY (Filed With SEC on February 23, 2011)

Standard Form of Agreement Between Owner and Design/Builder Part 2 (Filed With SEC on February 23, 2011)

RESTRICTED STOCK UNIT AGREEMENT CUBIST PHARMACEUTICALS, INC. (Filed With SEC on February 23, 2011)

Short-Term Incentive Plan (STI Plan) Terms and Conditions (Filed With SEC on February 22, 2011)

Re: License Agreement on FR264205 (Filed With SEC on October 29, 2010)

CUBIST PHARMACEUTICALS, INC. 2.50% CONVERTIBLE SENIOR NOTESDUE 2017 UNDERWRITING AGREEMENT (Filed With SEC on October 25, 2010)

CUBIST PHARMACEUTICALS, INC. 2.50% CONVERTIBLE SENIORNOTES DUE 2017 INDENTURE DATED AS OF OCTOBER 25, 2010 THE BANK OF NEW YORK MELLONTRUST COMPANY, N.A., AS TRUSTEE (Filed With SEC on October 25, 2010)

CONFIDENTIAL TREATMENT AMENDMENT NO. 2 (Filed With SEC on July 30, 2010)

CUBIST PHARMACEUTICALS, INC. 2010 EQUITY INCENTIVE PLAN (Filed With SEC on July 30, 2010)

STRICTLY CONFIDENTIAL (Filed With SEC on July 30, 2010)

CONFIDENTIAL TREATMENT Amendment # 3 (Filed With SEC on April 29, 2010)

CONFIDENTIAL TREATMENT (Filed With SEC on April 29, 2010)

CONFIDENTIAL TREATMENT AGREEMENT AND PLAN OF MERGER BY AND AMONG CUBIST PHARMACEUTICALS, INC., SD ACQUISITION CORPORATION, CALIXA THERAPEUTICS INC., and THE MEMBERS OF THE... (Filed With SEC on February 26, 2010)

CONFIDENTIAL TREATMENT LICENSE AGREEMENT (Filed With SEC on February 26, 2010)

CONFIDENTIAL TREATMENT FIRST AMENDMENT TO THE COMMERCIAL SERVICES AGREEMENT (Filed With SEC on February 26, 2010)

TENTH AMENDMENT TO LEASE (Filed With SEC on February 26, 2010)

CONFIDENTIAL TREATMENT SECONDAMENDMENT TO THE COMMERCIALSERVICES AGREEMENT (Filed With SEC on February 26, 2010)

CONFIDENTIAL TREATMENT THIRD AMENDMENT TO THE COMMERCIAL SERVICES AGREEMENT (Filed With SEC on February 26, 2010)

CONFIDENTIAL TREATMENT FOURTH AMENDMENT TO THE COMMERCIAL SERVICES AGREEMENT (Filed With SEC on February 26, 2010)

CONFIDENTIAL TREATMENT FIFTH AMENDMENT TO THE COMMERCIAL SERVICES AGREEMENT (Filed With SEC on February 26, 2010)

CONFIDENTIAL TREATMENT (Filed With SEC on February 26, 2010)

CONFIDENTIAL TREATMENT SIXTH AMENDMENT TO THE COMMERCIAL SERVICES AGREEMENT (Filed With SEC on February 26, 2010)

CUBIST PHARMACEUTICALS, INC. AMENDED AND RESTATED 1997 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on February 26, 2010)

Cubist Pharmaceuticals, Inc. Director Compensation, Benefits, Programs (Effective as of June 4, 2009) (Filed With SEC on February 26, 2010)

Short-Term Incentive Plan (STI Plan) Terms and Conditions (Filed With SEC on February 24, 2010)

Exhibit A Relocation Expenses (Filed With SEC on July 29, 2009)

CONFIDENTIAL TREATMENT ASSIGNMENT AND LICENSE AGREEMENT (Filed With SEC on February 27, 2009)

First Amendment to Manufacturing and Supply Agreement (Filed With SEC on February 27, 2009)

LICENSEAGREEMENT BY ANDBETWEEN CUBISTPHARMACEUTICALS, INC. AND CHIRONHEALTHCARE IRELAND LTD. October 2, 2003 (Filed With SEC on February 27, 2009)

FIRST AMENDMENT (Filed With SEC on February 27, 2009)

AMENDMENTNO. 4 to the MANUFACTURING AND SUPPLY AGREEMENT entered into as of September 30, 2001 by and between ACS Dobfar, SpA and Cubist Pharmaceuticals, Inc. (Filed With SEC on February 27, 2009)

AMENDMENT # 2 to the LICENSE AGREEMENT (Filed With SEC on February 27, 2009)

SIXTH AMENDMENT TO LEASE (Filed With SEC on February 27, 2009)

Exhibit A Relocation Expenses (Filed With SEC on February 27, 2009)

SEVENTH AMENDMENT TO LEASE (Filed With SEC on February 27, 2009)

EIGHTH AMENDMENT TO LEASE (Filed With SEC on February 27, 2009)

NINTH AMENDMENT TO LEASE (Filed With SEC on February 27, 2009)

RESTRICTED STOCK UNIT AGREEMENT CUBIST PHARMACEUTICALS, INC. (Filed With SEC on February 27, 2009)

Cubist Pharmaceuticals, Inc. Director Compensation Effective December 18, 2007 (Filed With SEC on February 27, 2009)

Short-Term Incentive Plan (STI Plan) Terms and Conditions (Filed With SEC on February 18, 2009)

RBS CITIZENS, NATIONAL ASSOCIATION LOAN AND SECURITY AGREEMENT (Filed With SEC on December 31, 2008)

REVOLVINGCREDIT NOTE (Filed With SEC on December 31, 2008)

CONFIDENTIAL TREATMENT LICENSE AND COLLABORATION AGREEMENT By and Between Dyax Corp. And Cubist Pharmaceuticals, Inc., (Filed With SEC on August 4, 2008)

CONFIDENTIALTREATMENT (Filed With SEC on August 4, 2008)

CUBIST PHARMACEUTICALS,INC. AMENDED AND RESTATED 2000 EQUITY INCENTIVE PLAN (Filed With SEC on May 12, 2008)

CUBIST PHARMACEUTICALS, INC. AMENDED AND RESTATED 2002 DIRECTORS EQUITY INCENTIVE PLAN (Filed With SEC on May 12, 2008)

STRICTLY CONFIDENTIAL (Filed With SEC on May 12, 2008)

Short-Term Incentive Plan (STI Plan) Terms and Conditions (Filed With SEC on February 15, 2008)

Short-Term Incentive Plan (STI Plan) Terms and Conditions (Filed With SEC on November 14, 2007)

CONFIDENTIALTREATMENT (Filed With SEC on August 3, 2007)

THIRD AMENDMENT TO LEASE (Filed With SEC on August 3, 2007)

LICENSE AGREEMENT BY AND BETWEEN CUBIST PHARMACEUTICALS, INC. AND CHIRON HEALTHCARE IRELAND LTD. October 2, 2003 (Filed With SEC on May 4, 2007)

CUBISTPHARMACEUTICALS, INC. (Filed With SEC on March 1, 2007)

Short-Term Incentive Plan (STI Plan) Terms and Conditions (Filed With SEC on December 13, 2006)

AMENDMENT NO. 4 tothe MANUFACTURINGAND SUPPLY AGREEMENT enteredinto as of September 30, 2001 byand between ACS Dobfar, SpA and Cubist Pharmaceuticals, Inc. (Filed With SEC on November 3, 2006)

CONFIDENTIALTREATMENT DEVELOPMENT AND SUPPLYAGREEMENT (Filed With SEC on August 9, 2006)

CUBIST PHARMACEUTICALS,INC. 2.25% CONVERTIBLESUBORDINATED NOTES DUE JUNE 15, 2013 INDENTURE Dated as of June 6, 2006 THE BANK OF NEW YORKTRUST COMPANY, N.A., As Trustee (Filed With SEC on June 9, 2006)

CUBIST PHARMACEUTICALS (Filed With SEC on March 1, 2006)

Short-Term Incentive Plan (STI Plan) Terms and Conditions (Filed With SEC on December 16, 2005)

CubistPharmaceuticals, Inc. DirectorCompensation, Benefits, Programs Effective January 1, 2006 (Filed With SEC on December 16, 2005)

CONFIDENTIAL TREATMENT (Filed With SEC on November 4, 2005)

CONFIDENTIAL TREATMENT PROCESSING SERVICES AGREEMENT (Filed With SEC on November 4, 2005)

CONFIDENTIALTREATMENT MANUFACTURINGAND SUPPLY AGREEMENT (Filed With SEC on November 4, 2005)

CONFIDENTIAL TREATMENT MANUFACTURING AND SUPPLY AGREEMENT (Filed With SEC on November 4, 2005)

CONFIDENTIALTREATMENT AMENDMENTNO. 2 to the MANUFACTURING AND SUPPLYAGREEMENT entered into as ofSeptember 30, 2001 by and between ACS Dobfar, SpA andCubist Pharmaceuticals, Inc. (Filed With SEC on November 4, 2005)

FIRST AMENDMENT TO LEASE (Filed With SEC on November 4, 2005)

RIGHTS AGREEMENT (Filed With SEC on August 5, 2005)

FIRST AMENDMENT TORIGHTS AGREEMENT (Filed With SEC on August 5, 2005)

AMENDMENT TO RIGHTS AGREEMENT (Filed With SEC on August 5, 2005)

THIRD AMENDMENT TO RIGHTS AGREEMENT (Filed With SEC on August 5, 2005)

CUBIST PHARMACEUTICALS, INC. FIRST AMENDMENT TO AMENDED AND RESTATED 2000 EQUITY INCENTIVE PLAN (Filed With SEC on August 5, 2005)

CUBIST PHARMACEUTICALS, INC. FIRST AMENDMENT TO AMENDED AND RESTATED 2002 DIRECTORS STOCK OPTION PLAN (Filed With SEC on August 5, 2005)

CUBIST PHARMACEUTICALS, INC. AMENDED AND RESTATED 1997 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on August 4, 2005)

AMENDMENT NO. 2 TOASSIGNMENT AND LICENSE AGREEMENT (Filed With SEC on May 5, 2005)

Short-Term Incentive Plan (STI Plan) Terms and Conditions for Managers (Filed With SEC on December 13, 2004)

9,316,700 Shares CUBIST PHARMACEUTICALS, INC. COMMON STOCK, $0.001 PAR VALUE UNDERWRITING AGREEMENT (Filed With SEC on November 24, 2004)

CONFIDENTIALTREATMENT LICENSEAGREEMENT (Filed With SEC on August 6, 2004)

CONFIDENTIAL TREATMENT Amendment #1 to the License Agreement dated October 2, 2003 made by and between Chiron Healthcare Ireland, Ltd. and Cubist Pharmaceuticals, Inc. (Filed With SEC on August 6, 2004)

ARTICLE I REFERENCE DATA (Filed With SEC on May 7, 2004)

Category

Industry

Companies

Contracts

CUBIST PHARMACEUTICALS INC Contracts & Agreements